Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults - 21/11/24

Doi : 10.14283/jpad.2022.1 
Jason K. Longhurst 1, 2, 3, , J.L. Cummings 4, S.E. John 4, B. Poston 5, J.V. Rider 3, 6, A.M. Salazar 4, V.R. Mishra 7, A. Ritter 7, J.Z. Caldwell 7, J.B. Miller 7, J.W. Kinney 4, M.R. Landers 3
1 Department of Physical Therapy and Athletic Training, Saint Louis University, 63104, Saint Louis, Missouri, USA 
2 Department of Neurorehabilitation, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA 
3 Department of Physical Therapy, University of Nevada, Las Vegas, USA 
4 Department of Brain Health, University of Nevada, Las Vegas, USA 
5 Department of Kinesiology and Nutrition Sciences, University of Nevada, Las Vegas, USA 
6 Department of Occupational Therapy, Touro University, Henderson, Nevada, USA 
7 Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA 

a jason.longhurst@health.slu.edu jason.longhurst@health.slu.edu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Preclinical Alzheimer’s disease (AD) provides an opportunity for the study and implementation of interventions and strategies aimed at delaying, mitigating, and preventing AD. While this preclinical state is an ideal target, it is difficult to identify efficiently and cost-effectively. Recent findings have suggested that cognitive-motor dual task paradigms may provide additional inference.

Objectives

Investigate the relationship between dual task performance and amyloidosis, suggestive of preclinical Alzheimer’s disease and whether dual task performance provides additional information beyond a cognitive composite, to help in the identification of amyloidosis.

Design

Cross-sectional.

Setting

Outpatient specialty brain health clinical research institution in the United States.

Participants

52 cognitively healthy adults.

Measurements

The data included demographics, amyloid standardized uptake value ratio obtained via florbetapir-PET, neuropsychological testing, apolipoprotien E genotype, and dual task performance measures. Data were analyzed via hierarchal multiple linear regression or logistic regression, controlling for age, education, and apolipoprotien E genotype. Receiver operating characteristic curves were plotted, and sensitivity and specificity calculated via 2×2 contingency tables.

Results

There was a moderate relationship (rs>.30) between motor and cognitive dual task effects and amyloid standardized uptake value ratio (ps<.042). A strong relationship (r=.58) was found between combined dual task effect, a measure of automaticity derived from dual task performance, and amyloid standardized uptake value ratio (p<.001). Additionally, combined dual task effect showed promise in its unique contributions to amyloid standardized uptake value ratio, accounting for 7.8% of amyloid standardized uptake value ratio variance beyond cognitive composite scores (p=.018). Additionally, when incorporated into the cognitive composite, combined dual task effect resulted in improved diagnostic accuracy for determining elevated amyloid standardized uptake value ratio, and increased the sensitivity and specificity of the cognitive composite.

Conclussion

Dual task performance using the combined dual task effect, a measure of automaticity, was a moderate predictor of cerebral amyloidosis, which suggests that it has utility in the screening and diagnosis of individuals for preclinical AD. Additionally, when combined with the cognitive composite, the combined dual task effect improves diagnostic accuracy. Further research is warranted.

Le texte complet de cet article est disponible en PDF.

Key words : Dual-task interference, amyloid, preclinical Alzheimer’s disease, screening, motor impairments


Plan


© 2022  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 9 - N° 2

P. 297-305 - avril 2022 Retour au numéro
Article précédent Article précédent
  • Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults
  • Catriona K. Lewis, O.M. Bernstein, J.D. Grill, D.L. Gillen, D.L. Sultzer
| Article suivant Article suivant
  • Disease Burden and Attributable Risk Factors of Alzheimer’s Disease and Dementia in China from 1990 to 2019
  • R. Li, J. Qi, Y. Yang, Y. Wu, P. Yin, M. Zhou, Z. Qian, M.H. LeBaige, S.E. McMillin, Haoyan Guo, Hualiang Lin

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.